Related Experiment Video
Updated: Jun 26, 2026

11:40
Quantitative Autonomic Testing
Published on: July 19, 2011
Clinical screening of autonomic dysfunction in multiple sclerosis.
Leigh A Hale1, Hitoshi Nukada, Lodewicus J Du Plessis
1Centre for Physiotherapy Research and School of Physiotherapy, University of Otago, Dunedin, New Zealand. leigh.hale@otago.ac.nz
Summary
People with multiple sclerosis (MS) and autonomic dysfunction may show altered heart rate responses during exercise. Monitoring heart rate during exercise tests is crucial for safety before starting rehabilitation programs.
Area of Science:
- Neurology
- Cardiology
- Exercise Physiology
Background:
- Multiple sclerosis (MS) can impact the autonomic nervous system, potentially affecting cardiovascular responses to physical activity.
- Individuals with MS and autonomic dysfunction may exhibit atypical heart rate patterns during exercise.
Purpose of the Study:
- To investigate differences in heart rate response during a simple cycle test among individuals with MS.
- To compare participants with MS and autonomic dysfunction against controls and MS participants without autonomic involvement.
Main Methods:
- A controlled cohort study involving 31 adults with MS and 31 age-matched healthy controls.
- Autonomic function was assessed using various tests, including deep breathing, Valsalva maneuver, postural change, and a cycle test.
- Continuous heart rate and blood pressure were monitored during testing.
Main Results:
- No significant differences in age, height, or weight were found between the MS and control groups.
- Sixteen percent (5/31) of participants with MS demonstrated abnormal autonomic function in laboratory tests.
- Two individuals with MS and abnormal autonomic function showed an atypical heart rate response during the cycle test.
Conclusions:
- Physiotherapists should monitor heart rate responses during dynamic exercise tests in individuals with MS before prescribing exercise programs.
- A delayed or attenuated heart rate response may indicate the need for formal autonomic laboratory testing to ensure patient safety.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

